Early‐onset rectal cancer may differ biologically and in its response to multimodality therapy, according to a large retrospective study of NCCN data.
Patients with muscle-invasive bladder cancer who underwent trimodal therapy had significantly poorer survival than those who underwent radical cystectomy alone.
Canadian Cancer Trials Group investigators say it's unclear if disease biology is different in younger patients or older ones are more likely to undergo CRC screening.
TROG 99.03 constitutes “the only high level evidence currently available to guide decision making for this group of patients,” says investigator Michael MacManus.
A 58-year-old man presents with a cough, dyspnea, and chest pain. Chest imaging shows the presence of pleural effusion, and a biopsy is obtained. What is your diagnosis?
In addition to significant improvements in 5-year OS and PFS with maintenance rituximab, there was a trend toward an association between maintenance and reduced transformation risk.
Germline BRCA mutations and other HR genes may offer biomarkers for response to this treatment.
The statement emphasizes strategies for multidisciplinary care, and proposes an algorithm for clinical management of bone metastasis in RCC.
PFS, tumor response, and safety outcomes were similar in patient cohorts under age 75 vs those 75 years of age and older.
Oncology nurse leaders share insights into the care of vulnerable oncology populations—from ED triage to tailored telehealth sessions for homeless populations.